Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Zippi applies for you, and finds you a job.
Clovis Oncology's peak revenue was $164.5M in 2020. The peak quarterly revenue was $43.3M in 2020(q4).
Clovis Oncology's revenue increased from $13.6m in 2014 to $148.8M currently. That's a 991.79% change in annual revenue.
| Fiscal year / year | Clovis Oncology revenue |
|---|---|
| 2014 | $13.6M |
| 2016 | $78,000 |
| 2017 | $55.5M |
| 2018 | $95.4M |
| 2019 | $143.0M |
| 2020 | $164.5M |
| 2021 | $148.8M |
How accurately did Clovis Oncology's revenue projections match actual performance?
Clovis Oncology saw the greatest revenue growth in 2017, when revenue increased by 71,067.95%.
Clovis Oncology had the lowest revenue growth in 2016, when revenue changed by -99.43%.
| Year | Clovis Oncology growth |
|---|---|
| 2016 | -99%↓ |
| 2017 | 71068%↑ |
| 2018 | 72%↑ |
| 2019 | 50%↑ |
| 2020 | 15%↑ |
| 2021 | -10%↓ |
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2014 | $13.6M | - | - | - |
| 2016 | - | - | - | $78,000 |
| 2017 | $7.0M | $14.6M | $16.8M | $17.0M |
| 2018 | $18.5M | $23.8M | $22.8M | $30.4M |
| 2019 | $33.1M | $33.0M | $37.6M | $39.3M |
| 2020 | $42.6M | $39.9M | $38.8M | $43.3M |
| 2021 | $38.1M | $36.8M | $37.9M | $36.0M |
| 2022 | $34.2M | $32.1M | $30.7M | - |
Do you work at Clovis Oncology?
Did Clovis Oncology meet its revenue projections?
| Industry | Pharmaceuticals, Biotechnology & Life Sciences |
| Company Type | Public |
| Employees Number | 468 |
| Date Founded | 2009 |
| Headquarters | Boulder, Colorado |
| Number of Locations | 3 |
| Revenue | $148.8M |
| Net Income | -$264,524,000 |
| Gross Proft | $109.9M (2021) |
| PE Ratio | -3.43 |
| Tax Rate | 0.0% |
| Market Capitalization | $907.2M |
| Total Assets | $472,833,000 |
| Ticker | CLVS |
Clovis Oncology received early financing of $145.0M on 2009-05-21.
| Series | Round size | Date |
|---|---|---|
| Series Unknown | $145M | 05/2009 |
| Investors | Security type |
|---|---|
| Abingworth | Series Unknown |
| New Enterprise Associates (NEA) | Series Unknown |
| ProQuest Investments | Series Unknown |
| Versant Ventures | Series Unknown |
| Frazier Healthcare Partners | Series Unknown |
| Aberdare Ventures | Series Unknown |
| Domain Associates | Series Unknown |
Clovis Oncology's top competitor, Merck, earned an annual revenue of $64.2B.
Clovis Oncology's smallest competitor is Ligand Pharmaceuticals with revenue of $241.5M last year.
| Company name | Average salary | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| Seagen | $85,008 | $2.0B | 900 | - |
| Regeneron | $85,589 | $14.2B | 9,123 | 342 |
| Gilead Sciences | $99,828 | $28.8B | 11,800 | 728 |
| Exelixis | $108,978 | $2.2B | 484 | 161 |
| Merck | $90,328 | $64.2B | 74,000 | 1,711 |
| Vertex Pharmaceuticals | $95,952 | $11.0B | 3,400 | 130 |
| Med Immune Inc | $56,355 | $1.7B | 5,000 | - |
| Intercept Pharmaceuticals | $93,850 | $285.7M | 437 | 1 |
| Ligand Pharmaceuticals | $82,001 | $241.5M | 116 | - |
| Amgen | $93,349 | $33.4B | 22,000 | 703 |
Zippia gives an in-depth look into the details of Clovis Oncology, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Clovis Oncology. The employee data is based on information from people who have self-reported their past or current employments at Clovis Oncology. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Clovis Oncology. The data presented on this page does not represent the view of Clovis Oncology and its employees or that of Zippia.
Clovis Oncology may also be known as or be related to CLOVIS ONCOLOGY INC., Clovis Oncology, Clovis Oncology Inc and Clovis Oncology, Inc.